What We're Reading: Page 194
Industry reads hand-picked by our editors
May 20, 2020
-
Forbes
The Man Betting $1 Billion That Pfizer Can Deliver A Vaccine By This Fall
-
BioCentury
Woodcock, Marks to recuse themselves from FDA reviews of COVID-19 products
-
Endpoints News
How a California biotech briefly tripled its value by hyping a Covid-19 ‘cure’
-
Bloomberg
Covid-19 Virus Mutation?: China's New Cluster Raises Concern
May 19, 2020
May 18, 2020
-
The New York Times
A Drug Company Wagers the U.S. Won’t Dare Charge It With Crimes
-
STAT
Utah embraced an unproven Covid-19 drug, then raced to course-correct
-
Reuters
GSK's long-acting injection beats Truvada in HIV prevention trial - Reuters
-
Axios
Why Deborah Birx is the real power doctor on the coronavirus task force
May 15, 2020
-
Bloomberg
Novartis CEO Says Covid-19 Vaccine May Take Until End of 2021
-
Kyodo News
Japan's health insurance to cover $1.5 million gene therapy drug
-
The Wall Street Journal
Why Big Investors Aren’t Betting It All on a Coronavirus Cure
-
STAT
FDA says Abbott’s 5-minute Covid-19 test may miss infected patients
May 14, 2020
-
STAT
Biotech’s new top lobbyist is a social justice advocate. Will industry listen?
-
Science
Emails offer look into whistleblower charges of cronyism behind potential COVID-19 drug
-
Bloomberg
Sanofi CEO's Remarks on Vaccine Plans Stir Outrage in France
-
POLITICO
White House to tap former pharmaceutical exec as 'therapeutics czar'
May 13, 2020
-
Bloomberg
French Drug Giant to Give U.S. Preference on Covid Vaccine
-
Science
Unveiling 'Warp Speed,' the White House's America-first push for a coronavirus vaccine
-
C&EN
Adenoviral vectors are the new COVID-19 vaccine front-runners. Can they overcome their checkered past?
-
The New York Times
He Was a Science Star. Then He Promoted a Questionable Cure for Covid-19.
May 12, 2020
-
The Wall Street Journal
Distribution of Key Drug Was Flawed, Says White House Official
-
Endpoints News
Merck to move global headquarters, returning to an old home
-
STAT
Prominent Broad Institute scientist leaves to lead R&D at Genentech
-
Bloomberg
NIH Director Talks Vaccines, Virus Mutation and Clinical Trials
Previous
